3 FTSE 100 stocks I’d buy with £20,000 now for the next 10 years

These FTSE 100 stocks are all part of Manika Premsingh’s portfolio, each bringing with them their unique long-term growth story. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The new tax year will soon be upon us. It is a good time to start thinking of making a Stocks and Shares ISA allocation of £20,000 now, in my view. There are plenty of FTSE 100 stocks to choose from. This is particularly so right now, when the stock markets are gaining ground. This also creates a challenge though. How do I choose between long-term investments and those that are likely to do well when investors are bullish? Here are three investments that I intend to hold for the next 10 years at least (in alphabetical order). 

#1. AstraZeneca: on the up and up

The pharmaceuticals biggie needs no introduction, especially not after Covid-19. I first bought AstraZeneca a few years ago, because it just looked like it was full of potential. The Anglo-Swedish company provides critical cancer treatments and is also expanding into new areas. Its recent acquisition of Alexion, which focuses on rare diseases is one such. The stock has a price-to-earnings (P/E) ratio of a huge 90 times, which indicates that it might be in for a correction. We will know for sure when the company releases full-year numbers in February. Over the next 10 years though, I expect it to rise more than fall, going by its profile and robust financial performance. 

#2. Royal Mail: FTSE 100 turnaround star

Not long ago, Royal Mail had tumbled out of the FTSE 100 index as friction between the company’s management and its strong trade union continued endlessly. Things started turning around for the stock with a change of guard. And the Covid-19 crisis created unexpectedly high demand for its parcel services. By last year its share price rose enough to make a return to the FTSE 100 again. The pandemic might be close to its end, but e-commerce is firmly established now as an industry of the future. And Royal Mail plays a critical role in that. The company has warned of a profit hit as it axed 700 jobs recently, but in the scheme of things, I would not base my investing decisions in the stock on this alone. I have bought the stock for the next 10 years.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

#3. SSE: it’s all about green energy

This one has long been a no-brainer for me. Over the long term, the world will only move towards clean and green energy sources. The FTSE 100 utility SSE is already there. Its financials are robust and it also has an above-average dividend yield of 5.3%. FTSE 100 has an average yield of 3.4%. It also beats inflation, which is at an awfully high 5%+ annual rate right now. And considering that it is a utility, dividends are unlikely to be axed even in otherwise bad times. Its stock price has been weak in the past few months, which is a downer. But I doubt if this will matter over the next 10 years, that is why I bought it on a dip. 

Should you buy AstraZeneca shares today?

Before you decide, please take a moment to review this first.

Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.

It’s called ‘5 Stocks for Trying to Build Wealth After 50’.

And it’s yours, free.

Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.

And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.

That’s why now could be an ideal time to secure this valuable investment research.

Mark’s ‘Foolish’ analysts have scoured the markets low and high.

This special report reveals 5 of his favourite long-term ‘Buys’.

Please, don’t make any big decisions before seeing them.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh owns AstraZeneca, Royal Mail, and SSE. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 high-yield dividend shares to consider buying for a retirement portfolio

Dividend shares can provide retirees with regular passive income in their golden years. Our writer picks out three with yields…

Read more »

Investing Articles

Tesla stock has halved. Could it now double – or halve again?

After a wild few months for Tesla stock, Christopher Ruane weighs some pros and cons of the investment case. Could…

Read more »

Investing Articles

Does it make sense to start buying shares as the stock market wobbles?

Does a rocky stock market make for a good or bad time to start buying shares? This writer reckons it…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

£15k of passive income a year? It’s possible with the right dividend strategy!

To figure out how much dividends are needed for a lucrative passive income stream, investors must understand which strategies get…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As US markets wobble, I’m listening to Warren Buffett!

The long career of billionaire investor Warren Buffett has included plenty of market turbulence. Here's what our writer's learnt from…

Read more »

UK money in a Jar on a background
Investing Articles

5 shares yielding over 5% to consider for a SIPP

Christopher Ruane introduces a handful of FTSE 100 and FTSE 250 shares he thinks an income-focussed SIPP investor should consider.

Read more »

Investing Articles

Here’s how an investor could invest a £20k ISA to target £1,500 of passive income per year

Can a £20,000 ISA throw off close to £30 per week on average of passive income when invested in blue-chip…

Read more »

Investing Articles

As gold hits $3,000, this FTSE 100 stock is primed for blast off

As Western institutions scramble to get as much gold as they can lay their hands on, Andrew Mackie believes this…

Read more »